

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.85573505 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.85573505 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.55458715 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.55458715 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.18515846 |
| 6 | glyoxylate metabolic process (GO:0046487) | 6.03947339 |
| 7 | lysine catabolic process (GO:0006554) | 5.95311991 |
| 8 | lysine metabolic process (GO:0006553) | 5.95311991 |
| 9 | cysteine metabolic process (GO:0006534) | 5.88052220 |
| 10 | drug transmembrane transport (GO:0006855) | 5.86824662 |
| 11 | urate metabolic process (GO:0046415) | 5.77936141 |
| 12 | indole-containing compound catabolic process (GO:0042436) | 5.53694213 |
| 13 | indolalkylamine catabolic process (GO:0046218) | 5.53694213 |
| 14 | tryptophan catabolic process (GO:0006569) | 5.53694213 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.15545712 |
| 16 | synaptic vesicle maturation (GO:0016188) | 5.14294614 |
| 17 | kynurenine metabolic process (GO:0070189) | 5.08494252 |
| 18 | bile acid biosynthetic process (GO:0006699) | 4.89745891 |
| 19 | drug catabolic process (GO:0042737) | 4.80656943 |
| 20 | drug transport (GO:0015893) | 4.80527713 |
| 21 | cellular ketone body metabolic process (GO:0046950) | 4.79319984 |
| 22 | serine family amino acid catabolic process (GO:0009071) | 4.62372346 |
| 23 | short-chain fatty acid metabolic process (GO:0046459) | 4.56615189 |
| 24 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.56207664 |
| 25 | aspartate family amino acid catabolic process (GO:0009068) | 4.55815911 |
| 26 | glutamate metabolic process (GO:0006536) | 4.47981041 |
| 27 | homocysteine metabolic process (GO:0050667) | 4.46301655 |
| 28 | aromatic amino acid family metabolic process (GO:0009072) | 4.43703582 |
| 29 | sulfur amino acid catabolic process (GO:0000098) | 4.42475322 |
| 30 | exogenous drug catabolic process (GO:0042738) | 4.36520755 |
| 31 | amino-acid betaine metabolic process (GO:0006577) | 4.28304557 |
| 32 | phosphate ion transport (GO:0006817) | 4.26252206 |
| 33 | cellular modified amino acid catabolic process (GO:0042219) | 4.25553227 |
| 34 | alpha-amino acid catabolic process (GO:1901606) | 4.24870819 |
| 35 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.23294750 |
| 36 | serine family amino acid metabolic process (GO:0009069) | 4.17278018 |
| 37 | ketone body metabolic process (GO:1902224) | 4.16999914 |
| 38 | alpha-linolenic acid metabolic process (GO:0036109) | 4.15827489 |
| 39 | phosphate ion transmembrane transport (GO:0035435) | 4.14610896 |
| 40 | response to mercury ion (GO:0046689) | 4.08928241 |
| 41 | cellular amino acid catabolic process (GO:0009063) | 4.07926683 |
| 42 | glutamate secretion (GO:0014047) | 4.03767817 |
| 43 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.03516022 |
| 44 | bile acid metabolic process (GO:0008206) | 3.98786227 |
| 45 | acetyl-CoA metabolic process (GO:0006084) | 3.96328005 |
| 46 | urea metabolic process (GO:0019627) | 3.94762122 |
| 47 | urea cycle (GO:0000050) | 3.94762122 |
| 48 | tyrosine metabolic process (GO:0006570) | 3.90718637 |
| 49 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.90654666 |
| 50 | serine family amino acid biosynthetic process (GO:0009070) | 3.88638988 |
| 51 | oxaloacetate metabolic process (GO:0006107) | 3.83886154 |
| 52 | organic cation transport (GO:0015695) | 3.83329796 |
| 53 | indolalkylamine metabolic process (GO:0006586) | 3.82910191 |
| 54 | amine catabolic process (GO:0009310) | 3.76124457 |
| 55 | cellular biogenic amine catabolic process (GO:0042402) | 3.76124457 |
| 56 | benzene-containing compound metabolic process (GO:0042537) | 3.75182622 |
| 57 | coenzyme catabolic process (GO:0009109) | 3.69944966 |
| 58 | nitrogen cycle metabolic process (GO:0071941) | 3.69520509 |
| 59 | 2-oxoglutarate metabolic process (GO:0006103) | 3.66851915 |
| 60 | aldehyde catabolic process (GO:0046185) | 3.62095285 |
| 61 | organic acid catabolic process (GO:0016054) | 3.58170609 |
| 62 | carboxylic acid catabolic process (GO:0046395) | 3.58170609 |
| 63 | proteasome assembly (GO:0043248) | 3.57857658 |
| 64 | negative regulation of fibrinolysis (GO:0051918) | 3.53513604 |
| 65 | cellular glucuronidation (GO:0052695) | 3.53238381 |
| 66 | protein carboxylation (GO:0018214) | 3.51181695 |
| 67 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.51181695 |
| 68 | fatty acid beta-oxidation (GO:0006635) | 3.51069717 |
| 69 | fatty acid oxidation (GO:0019395) | 3.47270890 |
| 70 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.46400848 |
| 71 | indole-containing compound metabolic process (GO:0042430) | 3.45521403 |
| 72 | high-density lipoprotein particle remodeling (GO:0034375) | 3.45095965 |
| 73 | synaptic vesicle exocytosis (GO:0016079) | 3.44972757 |
| 74 | quaternary ammonium group transport (GO:0015697) | 3.44810146 |
| 75 | regulation of fibrinolysis (GO:0051917) | 3.43545598 |
| 76 | branched-chain amino acid metabolic process (GO:0009081) | 3.42399383 |
| 77 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.42294837 |
| 78 | lipid oxidation (GO:0034440) | 3.41428232 |
| 79 | glucuronate metabolic process (GO:0019585) | 3.38494170 |
| 80 | uronic acid metabolic process (GO:0006063) | 3.38494170 |
| 81 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.37384078 |
| 82 | complement activation, alternative pathway (GO:0006957) | 3.36232280 |
| 83 | monocarboxylic acid catabolic process (GO:0072329) | 3.36157412 |
| 84 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.32819101 |
| 85 | branched-chain amino acid catabolic process (GO:0009083) | 3.32330437 |
| 86 | regulation of protein activation cascade (GO:2000257) | 3.31322948 |
| 87 | carnitine metabolic process (GO:0009437) | 3.31184011 |
| 88 | fatty acid catabolic process (GO:0009062) | 3.30864282 |
| 89 | ethanol oxidation (GO:0006069) | 3.28836234 |
| 90 | glutathione biosynthetic process (GO:0006750) | 3.28416227 |
| 91 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.27592023 |
| 92 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.27592023 |
| 93 | very long-chain fatty acid metabolic process (GO:0000038) | 3.26650701 |
| 94 | negative regulation of sterol transport (GO:0032372) | 3.22404354 |
| 95 | negative regulation of cholesterol transport (GO:0032375) | 3.22404354 |
| 96 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.20345913 |
| 97 | valine metabolic process (GO:0006573) | 3.19097033 |
| 98 | drug metabolic process (GO:0017144) | 3.18452388 |
| 99 | flavonoid metabolic process (GO:0009812) | 3.18437719 |
| 100 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.16165098 |
| 101 | heme transport (GO:0015886) | 3.14105549 |
| 102 | glycine metabolic process (GO:0006544) | 3.13657070 |
| 103 | sodium ion export (GO:0071436) | 3.12633002 |
| 104 | small molecule catabolic process (GO:0044282) | 3.12135214 |
| 105 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.09472105 |
| 106 | arginine metabolic process (GO:0006525) | 3.08530532 |
| 107 | dicarboxylic acid metabolic process (GO:0043648) | 3.07078263 |
| 108 | regulation of complement activation (GO:0030449) | 3.07060631 |
| 109 | triglyceride homeostasis (GO:0070328) | 3.07035721 |
| 110 | acylglycerol homeostasis (GO:0055090) | 3.07035721 |
| 111 | regulation of bile acid biosynthetic process (GO:0070857) | 3.06316941 |
| 112 | glutathione derivative biosynthetic process (GO:1901687) | 3.05769967 |
| 113 | glutathione derivative metabolic process (GO:1901685) | 3.05769967 |
| 114 | cellular potassium ion homeostasis (GO:0030007) | 3.05117263 |
| 115 | response to phenylpropanoid (GO:0080184) | 3.04041280 |
| 116 | neurotransmitter secretion (GO:0007269) | 3.02862378 |
| 117 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.00880125 |
| 118 | sleep (GO:0030431) | 3.00614208 |
| 119 | regulation of oxidative phosphorylation (GO:0002082) | 2.90762118 |
| 120 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.89514811 |
| 121 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.89078709 |
| 122 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.83203242 |
| 123 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.82127108 |
| 124 | regulation of synaptic vesicle transport (GO:1902803) | 2.81747671 |
| 125 | tricarboxylic acid cycle (GO:0006099) | 2.79656360 |
| 126 | ADP metabolic process (GO:0046031) | 2.77581269 |
| 127 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.76828082 |
| 128 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.75515642 |
| 129 | maturation of 5.8S rRNA (GO:0000460) | 2.73653316 |
| 130 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.66213801 |
| 131 | ATP synthesis coupled proton transport (GO:0015986) | 2.66207253 |
| 132 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.66207253 |
| 133 | tetrahydrofolate metabolic process (GO:0046653) | 2.64300140 |
| 134 | NADH metabolic process (GO:0006734) | 2.62808037 |
| 135 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.61861963 |
| 136 | pseudouridine synthesis (GO:0001522) | 2.58063460 |
| 137 | dicarboxylic acid catabolic process (GO:0043649) | 2.57321653 |
| 138 | respiratory chain complex IV assembly (GO:0008535) | 2.57105372 |
| 139 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.56175781 |
| 140 | ribosome assembly (GO:0042255) | 2.54965797 |
| 141 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.54709732 |
| 142 | purine nucleoside diphosphate metabolic process (GO:0009135) | 2.53886999 |
| 143 | purine ribonucleoside diphosphate metabolic process (GO:0009179) | 2.53886999 |
| 144 | pteridine-containing compound metabolic process (GO:0042558) | 2.53554080 |
| 145 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.53235368 |
| 146 | nucleotide transmembrane transport (GO:1901679) | 2.52780073 |
| 147 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.52490276 |
| 148 | respiratory electron transport chain (GO:0022904) | 2.52397601 |
| 149 | vesicle docking involved in exocytosis (GO:0006904) | 2.48108706 |
| 150 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.48043521 |
| 151 | L-methionine salvage (GO:0071267) | 2.46981997 |
| 152 | L-methionine biosynthetic process (GO:0071265) | 2.46981997 |
| 153 | amino acid salvage (GO:0043102) | 2.46981997 |
| 154 | electron transport chain (GO:0022900) | 2.45071582 |
| 155 | negative regulation of ligase activity (GO:0051352) | 2.45060778 |
| 156 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.45060778 |
| 157 | response to interferon-beta (GO:0035456) | 2.44121363 |
| 158 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.43566551 |
| 159 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.43566551 |
| 160 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.43510845 |
| 161 | neurotransmitter uptake (GO:0001504) | 2.43382700 |
| 162 | daunorubicin metabolic process (GO:0044597) | 2.43066216 |
| 163 | polyketide metabolic process (GO:0030638) | 2.43066216 |
| 164 | doxorubicin metabolic process (GO:0044598) | 2.43066216 |
| 165 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.42623987 |
| 166 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.41683090 |
| 167 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.41683090 |
| 168 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.41683090 |
| 169 | positive regulation of vesicle fusion (GO:0031340) | 2.41277944 |
| 170 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.41079827 |
| 171 | hepatocyte apoptotic process (GO:0097284) | 2.40664987 |
| 172 | positive regulation of prostaglandin secretion (GO:0032308) | 2.39420101 |
| 173 | ribonucleoside diphosphate metabolic process (GO:0009185) | 2.39150882 |
| 174 | detection of calcium ion (GO:0005513) | 2.38817042 |
| 175 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.38427332 |
| 176 | oxidative phosphorylation (GO:0006119) | 2.37907760 |
| 177 | DNA deamination (GO:0045006) | 2.36661057 |
| 178 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.35387197 |
| 179 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.35346138 |
| 180 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.35346138 |
| 181 | positive regulation of ligase activity (GO:0051351) | 2.34882411 |
| 182 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.34028898 |
| 183 | neurotransmitter transport (GO:0006836) | 2.33158896 |
| 184 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.33132124 |
| 185 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.31977534 |
| 186 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.31977534 |
| 187 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.31242354 |
| 188 | regulation of cellular amine metabolic process (GO:0033238) | 2.29362027 |
| 189 | chaperone-mediated protein transport (GO:0072321) | 2.29122394 |
| 190 | vesicle docking (GO:0048278) | 2.28658234 |
| 191 | cytochrome complex assembly (GO:0017004) | 2.27039811 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.61862595 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.50826931 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.85930561 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.38312869 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.28042128 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.05229918 |
| 7 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.99138563 |
| 8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.79894741 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.42654109 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.41055166 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.20377757 |
| 12 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.13905529 |
| 13 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.12303544 |
| 14 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.04825536 |
| 15 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.95977826 |
| 16 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.91951146 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.81647413 |
| 18 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.79060529 |
| 19 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.59007537 |
| 20 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.47383779 |
| 21 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.33843518 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.25771959 |
| 23 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.16550796 |
| 24 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.07088920 |
| 25 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.99923788 |
| 26 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.97116711 |
| 27 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.95243948 |
| 28 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.94830860 |
| 29 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.92854567 |
| 30 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.92284180 |
| 31 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.92205305 |
| 32 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.87108913 |
| 33 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.77573097 |
| 34 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.77415259 |
| 35 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.71532165 |
| 36 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.70800595 |
| 37 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.70331495 |
| 38 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.68790206 |
| 39 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.67484293 |
| 40 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.66221967 |
| 41 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.66125071 |
| 42 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.66018382 |
| 43 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.63399928 |
| 44 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.61710325 |
| 45 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.61498726 |
| 46 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.59532584 |
| 47 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.57838943 |
| 48 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.54301823 |
| 49 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.51731393 |
| 50 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.49978816 |
| 51 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.49665846 |
| 52 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.48260477 |
| 53 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.46304748 |
| 54 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.43753021 |
| 55 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.42202244 |
| 56 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.40717273 |
| 57 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.40376732 |
| 58 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.39534220 |
| 59 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.39499181 |
| 60 | VDR_22108803_ChIP-Seq_LS180_Human | 1.38777781 |
| 61 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.38540636 |
| 62 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.37534904 |
| 63 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.34789993 |
| 64 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.34789993 |
| 65 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34567527 |
| 66 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.33226352 |
| 67 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.32792936 |
| 68 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32321359 |
| 69 | MYB_26560356_Chip-Seq_TH2_Human | 1.32150962 |
| 70 | GATA3_26560356_Chip-Seq_TH2_Human | 1.30670963 |
| 71 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.28232445 |
| 72 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.26540262 |
| 73 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.26066381 |
| 74 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.26052643 |
| 75 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.26052643 |
| 76 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.25934371 |
| 77 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.24827673 |
| 78 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.24427383 |
| 79 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23822591 |
| 80 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.22081306 |
| 81 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.21443586 |
| 82 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.20185810 |
| 83 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.19617032 |
| 84 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.18170894 |
| 85 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.17673873 |
| 86 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.17321532 |
| 87 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17038961 |
| 88 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.15461891 |
| 89 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.15004057 |
| 90 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.13847468 |
| 91 | GATA1_22025678_ChIP-Seq_K562_Human | 1.13209327 |
| 92 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.13200487 |
| 93 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.13064183 |
| 94 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.12530000 |
| 95 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.11798089 |
| 96 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.10593085 |
| 97 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10275058 |
| 98 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.10243483 |
| 99 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.09982031 |
| 100 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.08012637 |
| 101 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.07839824 |
| 102 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.07663359 |
| 103 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.07217888 |
| 104 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.06632906 |
| 105 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.05693065 |
| 106 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.05454795 |
| 107 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.04505003 |
| 108 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.04440856 |
| 109 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.03316990 |
| 110 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.02497164 |
| 111 | * SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.01951248 |
| 112 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.01545941 |
| 113 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.01226644 |
| 114 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.01113334 |
| 115 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.00703914 |
| 116 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.00605269 |
| 117 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.99958366 |
| 118 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.99413027 |
| 119 | GATA3_26560356_Chip-Seq_TH1_Human | 0.99315756 |
| 120 | * KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.98193231 |
| 121 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.98005289 |
| 122 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.97896938 |
| 123 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97103514 |
| 124 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.96956838 |
| 125 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.96956838 |
| 126 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.96916537 |
| 127 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.96412278 |
| 128 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.96108830 |
| 129 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95632928 |
| 130 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.94335534 |
| 131 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.94014981 |
| 132 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.93964929 |
| 133 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.93623711 |
| 134 | RXR_22108803_ChIP-Seq_LS180_Human | 0.93596442 |
| 135 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.93213175 |
| 136 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.92919233 |
| 137 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.92827455 |
| 138 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.92599419 |
| 139 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.92320408 |
| 140 | * CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.92283319 |
| 141 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.92200027 |
| 142 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.91623067 |
| 143 | AR_25329375_ChIP-Seq_VCAP_Human | 0.90908001 |
| 144 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.90472297 |
| 145 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.90413167 |
| 146 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.90393236 |
| 147 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.90260532 |
| 148 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.90219169 |
| 149 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.90031308 |
| 150 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.89766352 |
| 151 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.89517592 |
| 152 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.89311972 |
| 153 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.89291762 |
| 154 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.88473598 |
| 155 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.88407555 |
| 156 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.88065533 |
| 157 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.87638108 |
| 158 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87442710 |
| 159 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.86739733 |
| 160 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.85355333 |
| 161 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.85228926 |
| 162 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.84906608 |
| 163 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.84751458 |
| 164 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.84571767 |
| 165 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.83539960 |
| 166 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.83278368 |
| 167 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80889161 |
| 168 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.80516812 |
| 169 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.80427226 |
| 170 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.80105060 |
| 171 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.79942431 |
| 172 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.79863087 |
| 173 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.79534385 |
| 174 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.78977075 |
| 175 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.78786039 |
| 176 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.78760427 |
| 177 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.76258095 |
| 178 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.76137022 |
| 179 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.75601247 |
| 180 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.75498826 |
| 181 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.75054218 |
| 182 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.74566899 |
| 183 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.74248523 |
| 184 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.73513673 |
| 185 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 0.72884726 |
| 186 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 0.72884726 |
| 187 | KDM2B_26808549_Chip-Seq_REH_Human | 0.72181264 |
| 188 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.71793713 |
| 189 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.70777888 |
| 190 | STAT3_23295773_ChIP-Seq_U87_Human | 0.70226452 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.70848495 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 6.78515450 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.82132909 |
| 4 | MP0005365_abnormal_bile_salt | 4.64954337 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.37283661 |
| 6 | MP0005332_abnormal_amino_acid | 3.68140279 |
| 7 | MP0003195_calcinosis | 3.56183128 |
| 8 | MP0004019_abnormal_vitamin_homeostasis | 3.19199035 |
| 9 | MP0003252_abnormal_bile_duct | 3.12186336 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 3.09528089 |
| 11 | MP0004043_abnormal_pH_regulation | 2.84366759 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.43458116 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 2.30935408 |
| 14 | MP0004859_abnormal_synaptic_plasticity | 2.21705934 |
| 15 | MP0009643_abnormal_urine_homeostasis | 2.05376036 |
| 16 | MP0008057_abnormal_DNA_replication | 1.96472642 |
| 17 | MP0003880_abnormal_central_pattern | 1.95655013 |
| 18 | MP0001666_abnormal_nutrient_absorption | 1.88532171 |
| 19 | MP0005636_abnormal_mineral_homeostasis | 1.83919133 |
| 20 | MP0001765_abnormal_ion_homeostasis | 1.79943542 |
| 21 | MP0003329_amyloid_beta_deposits | 1.78809446 |
| 22 | MP0005083_abnormal_biliary_tract | 1.77936296 |
| 23 | MP0001835_abnormal_antigen_presentation | 1.75657782 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.72788954 |
| 25 | MP0002118_abnormal_lipid_homeostasis | 1.71655615 |
| 26 | MP0002006_tumorigenesis | 1.70979824 |
| 27 | MP0003191_abnormal_cellular_cholesterol | 1.64746648 |
| 28 | MP0009840_abnormal_foam_cell | 1.58656648 |
| 29 | MP0000569_abnormal_digit_pigmentation | 1.56610095 |
| 30 | MP0002148_abnormal_hypersensitivity_rea | 1.53219639 |
| 31 | MP0010094_abnormal_chromosome_stability | 1.51185583 |
| 32 | MP0005319_abnormal_enzyme/_coenzyme | 1.50808574 |
| 33 | MP0000685_abnormal_immune_system | 1.43409742 |
| 34 | MP0002876_abnormal_thyroid_physiology | 1.42669130 |
| 35 | MP0008058_abnormal_DNA_repair | 1.42353818 |
| 36 | MP0005464_abnormal_platelet_physiology | 1.40821635 |
| 37 | MP0001764_abnormal_homeostasis | 1.37857237 |
| 38 | MP0003763_abnormal_thymus_physiology | 1.37525190 |
| 39 | MP0001756_abnormal_urination | 1.37085253 |
| 40 | MP0000604_amyloidosis | 1.36718811 |
| 41 | MP0002166_altered_tumor_susceptibility | 1.34565438 |
| 42 | MP0005451_abnormal_body_composition | 1.33514086 |
| 43 | MP0003866_abnormal_defecation | 1.32800834 |
| 44 | MP0010234_abnormal_vibrissa_follicle | 1.30061530 |
| 45 | MP0000609_abnormal_liver_physiology | 1.29468882 |
| 46 | MP0005000_abnormal_immune_tolerance | 1.27817619 |
| 47 | MP0005165_increased_susceptibility_to | 1.27801891 |
| 48 | MP0005671_abnormal_response_to | 1.27593762 |
| 49 | MP0003186_abnormal_redox_activity | 1.26986981 |
| 50 | MP0002396_abnormal_hematopoietic_system | 1.25844421 |
| 51 | MP0003868_abnormal_feces_composition | 1.24597819 |
| 52 | MP0010386_abnormal_urinary_bladder | 1.23688396 |
| 53 | MP0003635_abnormal_synaptic_transmissio | 1.21509657 |
| 54 | MP0009785_altered_susceptibility_to | 1.21385070 |
| 55 | MP0002136_abnormal_kidney_physiology | 1.20131400 |
| 56 | MP0005535_abnormal_body_temperature | 1.17415924 |
| 57 | MP0002064_seizures | 1.15014358 |
| 58 | MP0005410_abnormal_fertilization | 1.14585416 |
| 59 | MP0009745_abnormal_behavioral_response | 1.14230571 |
| 60 | MP0006036_abnormal_mitochondrial_physio | 1.13637926 |
| 61 | MP0008569_lethality_at_weaning | 1.12747999 |
| 62 | MP0003045_fibrosis | 1.11879878 |
| 63 | MP0002693_abnormal_pancreas_physiology | 1.11306048 |
| 64 | MP0003786_premature_aging | 1.11292887 |
| 65 | MP0004885_abnormal_endolymph | 1.09975930 |
| 66 | MP0005084_abnormal_gallbladder_morpholo | 1.09747075 |
| 67 | MP0004270_analgesia | 1.09249012 |
| 68 | MP0002063_abnormal_learning/memory/cond | 1.06521266 |
| 69 | MP0001800_abnormal_humoral_immune | 1.04814272 |
| 70 | MP0002398_abnormal_bone_marrow | 1.04594423 |
| 71 | MP0003690_abnormal_glial_cell | 1.02991308 |
| 72 | MP0004145_abnormal_muscle_electrophysio | 1.02577675 |
| 73 | MP0002452_abnormal_antigen_presenting | 1.02226813 |
| 74 | MP0005423_abnormal_somatic_nervous | 0.99507094 |
| 75 | MP0002420_abnormal_adaptive_immunity | 0.99012483 |
| 76 | MP0002723_abnormal_immune_serum | 0.98761378 |
| 77 | MP0001819_abnormal_immune_cell | 0.96630018 |
| 78 | MP0003011_delayed_dark_adaptation | 0.95307945 |
| 79 | MP0008007_abnormal_cellular_replicative | 0.95031061 |
| 80 | MP0000920_abnormal_myelination | 0.92646811 |
| 81 | MP0002736_abnormal_nociception_after | 0.91221958 |
| 82 | MP0001968_abnormal_touch/_nociception | 0.91190990 |
| 83 | MP0001845_abnormal_inflammatory_respons | 0.90561545 |
| 84 | MP0004957_abnormal_blastocyst_morpholog | 0.89896180 |
| 85 | MP0008873_increased_physiological_sensi | 0.88080795 |
| 86 | MP0000230_abnormal_systemic_arterial | 0.87678453 |
| 87 | MP0000689_abnormal_spleen_morphology | 0.87036849 |
| 88 | MP0008877_abnormal_DNA_methylation | 0.86916860 |
| 89 | MP0001440_abnormal_grooming_behavior | 0.86745366 |
| 90 | MP0001970_abnormal_pain_threshold | 0.86144379 |
| 91 | MP0003111_abnormal_nucleus_morphology | 0.85160181 |
| 92 | MP0004782_abnormal_surfactant_physiolog | 0.84555112 |
| 93 | MP0005058_abnormal_lysosome_morphology | 0.84335261 |
| 94 | MP0004947_skin_inflammation | 0.83377421 |
| 95 | MP0010678_abnormal_skin_adnexa | 0.83178562 |
| 96 | MP0001881_abnormal_mammary_gland | 0.82874676 |
| 97 | MP0000716_abnormal_immune_system | 0.80798691 |
| 98 | MP0003075_altered_response_to | 0.80650659 |
| 99 | MP0001986_abnormal_taste_sensitivity | 0.80096375 |
| 100 | MP0002572_abnormal_emotion/affect_behav | 0.79798197 |
| 101 | MP0003633_abnormal_nervous_system | 0.79699827 |
| 102 | MP0001790_abnormal_immune_system | 0.79295774 |
| 103 | MP0005387_immune_system_phenotype | 0.79295774 |
| 104 | MP0001661_extended_life_span | 0.78344948 |
| 105 | MP0001486_abnormal_startle_reflex | 0.78303198 |
| 106 | MP0008874_decreased_physiological_sensi | 0.76111827 |
| 107 | MP0009642_abnormal_blood_homeostasis | 0.76033338 |
| 108 | MP0002272_abnormal_nervous_system | 0.75156133 |
| 109 | MP0009697_abnormal_copulation | 0.74962923 |
| 110 | MP0002837_dystrophic_cardiac_calcinosis | 0.74411792 |
| 111 | MP0002822_catalepsy | 0.71668525 |
| 112 | MP0008872_abnormal_physiological_respon | 0.68642364 |
| 113 | MP0003631_nervous_system_phenotype | 0.67043515 |
| 114 | MP0009780_abnormal_chondrocyte_physiolo | 0.66620728 |
| 115 | MP0002078_abnormal_glucose_homeostasis | 0.66516327 |
| 116 | MP0009046_muscle_twitch | 0.66049257 |
| 117 | MP0004147_increased_porphyrin_level | 0.65922565 |
| 118 | MP0006035_abnormal_mitochondrial_morpho | 0.65871257 |
| 119 | MP0000538_abnormal_urinary_bladder | 0.65699907 |
| 120 | MP0003656_abnormal_erythrocyte_physiolo | 0.64146977 |
| 121 | MP0003638_abnormal_response/metabolism_ | 0.63337455 |
| 122 | MP0000598_abnormal_liver_morphology | 0.63091351 |
| 123 | MP0004142_abnormal_muscle_tone | 0.62946245 |
| 124 | MP0003879_abnormal_hair_cell | 0.62941090 |
| 125 | MP0001958_emphysema | 0.62641221 |
| 126 | MP0009764_decreased_sensitivity_to | 0.62093667 |
| 127 | MP0002067_abnormal_sensory_capabilities | 0.61933346 |
| 128 | MP0005376_homeostasis/metabolism_phenot | 0.61293176 |
| 129 | MP0002168_other_aberrant_phenotype | 0.61268282 |
| 130 | MP0002735_abnormal_chemical_nociception | 0.60829478 |
| 131 | MP0002069_abnormal_eating/drinking_beha | 0.60733365 |
| 132 | MP0005647_abnormal_sex_gland | 0.57859805 |
| 133 | MP0001501_abnormal_sleep_pattern | 0.56985487 |
| 134 | MP0002928_abnormal_bile_duct | 0.54900870 |
| 135 | MP0002229_neurodegeneration | 0.54494586 |
| 136 | MP0005646_abnormal_pituitary_gland | 0.54286057 |
| 137 | MP0001177_atelectasis | 0.54062790 |
| 138 | MP0008961_abnormal_basal_metabolism | 0.53761782 |
| 139 | MP0005551_abnormal_eye_electrophysiolog | 0.52149963 |
| 140 | MP0002066_abnormal_motor_capabilities/c | 0.51821496 |
| 141 | MP0003172_abnormal_lysosome_physiology | 0.51127611 |
| 142 | MP0001905_abnormal_dopamine_level | 0.50976761 |
| 143 | MP0008469_abnormal_protein_level | 0.50881816 |
| 144 | MP0005166_decreased_susceptibility_to | 0.50708836 |
| 145 | MP0005595_abnormal_vascular_smooth | 0.50440909 |
| 146 | MP0002734_abnormal_mechanical_nocicepti | 0.50004937 |
| 147 | MP0002971_abnormal_brown_adipose | 0.49818065 |
| 148 | MP0000747_muscle_weakness | 0.48103614 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.54847175 |
| 2 | Gout (HP:0001997) | 5.06695578 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 4.80085950 |
| 4 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.65912128 |
| 5 | Increased circulating renin level (HP:0000848) | 4.55955059 |
| 6 | Hyperglycinuria (HP:0003108) | 4.49407664 |
| 7 | Deep venous thrombosis (HP:0002625) | 4.39416929 |
| 8 | Ketosis (HP:0001946) | 4.31940586 |
| 9 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.26990625 |
| 10 | Abnormality of glycine metabolism (HP:0010895) | 4.26990625 |
| 11 | Xanthomatosis (HP:0000991) | 4.23750887 |
| 12 | Hypokalemic alkalosis (HP:0001949) | 4.14180747 |
| 13 | Metabolic alkalosis (HP:0200114) | 4.13939262 |
| 14 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.99389473 |
| 15 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.95164625 |
| 16 | Ketoacidosis (HP:0001993) | 3.94556868 |
| 17 | Hyperglycinemia (HP:0002154) | 3.89484897 |
| 18 | Hyperammonemia (HP:0001987) | 3.83174603 |
| 19 | Abnormality of purine metabolism (HP:0004352) | 3.78679759 |
| 20 | Hypomagnesemia (HP:0002917) | 3.74388945 |
| 21 | Hyperactive renin-angiotensin system (HP:0000841) | 3.72917344 |
| 22 | Proximal tubulopathy (HP:0000114) | 3.70493340 |
| 23 | Increased purine levels (HP:0004368) | 3.68346031 |
| 24 | Hyperuricemia (HP:0002149) | 3.68346031 |
| 25 | Alkalosis (HP:0001948) | 3.67721514 |
| 26 | Hypobetalipoproteinemia (HP:0003563) | 3.61236092 |
| 27 | Prolonged partial thromboplastin time (HP:0003645) | 3.59448896 |
| 28 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.43253521 |
| 29 | Polyuria (HP:0000103) | 3.41409749 |
| 30 | Delayed CNS myelination (HP:0002188) | 3.41058863 |
| 31 | Abnormal urine output (HP:0012590) | 3.37487322 |
| 32 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.28639037 |
| 33 | Abnormality of nucleobase metabolism (HP:0010932) | 3.22572456 |
| 34 | Hyperlipoproteinemia (HP:0010980) | 3.21554656 |
| 35 | Abnormality of chloride homeostasis (HP:0011422) | 3.17271587 |
| 36 | Abnormality of renal excretion (HP:0011036) | 3.15773171 |
| 37 | Abnormality of magnesium homeostasis (HP:0004921) | 3.13493265 |
| 38 | Increased hepatocellular lipid droplets (HP:0006565) | 3.06967316 |
| 39 | Vascular calcification (HP:0004934) | 3.05409969 |
| 40 | Generalized aminoaciduria (HP:0002909) | 3.02524205 |
| 41 | Papilledema (HP:0001085) | 3.01119342 |
| 42 | Glycosuria (HP:0003076) | 3.00945068 |
| 43 | Abnormality of urine glucose concentration (HP:0011016) | 3.00945068 |
| 44 | Metabolic acidosis (HP:0001942) | 2.97782920 |
| 45 | Febrile seizures (HP:0002373) | 2.96182877 |
| 46 | Hyperventilation (HP:0002883) | 2.95154600 |
| 47 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.94315042 |
| 48 | Autoimmune hemolytic anemia (HP:0001890) | 2.92578446 |
| 49 | Complement deficiency (HP:0004431) | 2.90407601 |
| 50 | Lipid accumulation in hepatocytes (HP:0006561) | 2.84830383 |
| 51 | Joint hemorrhage (HP:0005261) | 2.83624640 |
| 52 | Increased CSF lactate (HP:0002490) | 2.82950846 |
| 53 | Renal Fanconi syndrome (HP:0001994) | 2.81462231 |
| 54 | Mitochondrial inheritance (HP:0001427) | 2.80634633 |
| 55 | Abnormality of B cell number (HP:0010975) | 2.77723519 |
| 56 | Abnormality of methionine metabolism (HP:0010901) | 2.76802976 |
| 57 | Lethargy (HP:0001254) | 2.72960667 |
| 58 | Fat malabsorption (HP:0002630) | 2.72197084 |
| 59 | Polydipsia (HP:0001959) | 2.71031636 |
| 60 | Abnormal drinking behavior (HP:0030082) | 2.71031636 |
| 61 | Cardiovascular calcification (HP:0011915) | 2.70320054 |
| 62 | Dicarboxylic aciduria (HP:0003215) | 2.69365202 |
| 63 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.69365202 |
| 64 | Focal seizures (HP:0007359) | 2.68966996 |
| 65 | Abnormality of serum amino acid levels (HP:0003112) | 2.66642968 |
| 66 | Increased serum lactate (HP:0002151) | 2.64252728 |
| 67 | Epidermoid cyst (HP:0200040) | 2.63962354 |
| 68 | Confusion (HP:0001289) | 2.63230806 |
| 69 | Hypolipoproteinemia (HP:0010981) | 2.62717752 |
| 70 | Acute necrotizing encephalopathy (HP:0006965) | 2.61703574 |
| 71 | 3-Methylglutaconic aciduria (HP:0003535) | 2.60639819 |
| 72 | Fatigue (HP:0012378) | 2.59080869 |
| 73 | Abnormality of renin-angiotensin system (HP:0000847) | 2.58042819 |
| 74 | Hypoglycemic seizures (HP:0002173) | 2.56764898 |
| 75 | Vomiting (HP:0002013) | 2.56120731 |
| 76 | Hyperphosphaturia (HP:0003109) | 2.55922392 |
| 77 | Hyperaldosteronism (HP:0000859) | 2.55882512 |
| 78 | B lymphocytopenia (HP:0010976) | 2.55567846 |
| 79 | Progressive macrocephaly (HP:0004481) | 2.54810799 |
| 80 | Cerebral edema (HP:0002181) | 2.54660043 |
| 81 | Delusions (HP:0000746) | 2.54420359 |
| 82 | Hypoglycemic coma (HP:0001325) | 2.53875533 |
| 83 | Abnormality of the common coagulation pathway (HP:0010990) | 2.50012676 |
| 84 | Malnutrition (HP:0004395) | 2.49110237 |
| 85 | Rickets (HP:0002748) | 2.46884371 |
| 86 | Hepatocellular necrosis (HP:0001404) | 2.46167089 |
| 87 | Epileptic encephalopathy (HP:0200134) | 2.43597128 |
| 88 | Conjugated hyperbilirubinemia (HP:0002908) | 2.43196660 |
| 89 | Increased intramyocellular lipid droplets (HP:0012240) | 2.42833774 |
| 90 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.38385573 |
| 91 | Enlarged kidneys (HP:0000105) | 2.38103514 |
| 92 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.37262679 |
| 93 | Aplastic anemia (HP:0001915) | 2.34876860 |
| 94 | Irritability (HP:0000737) | 2.34412658 |
| 95 | Renal salt wasting (HP:0000127) | 2.33419151 |
| 96 | Panhypogammaglobulinemia (HP:0003139) | 2.33364681 |
| 97 | Tetany (HP:0001281) | 2.32738089 |
| 98 | Sensorimotor neuropathy (HP:0007141) | 2.32213145 |
| 99 | Palpitations (HP:0001962) | 2.31855154 |
| 100 | Hydroxyprolinuria (HP:0003080) | 2.30715380 |
| 101 | Abnormality of proline metabolism (HP:0010907) | 2.30715380 |
| 102 | Hyperbilirubinemia (HP:0002904) | 2.28481991 |
| 103 | Neonatal onset (HP:0003623) | 2.27497684 |
| 104 | Atonic seizures (HP:0010819) | 2.27314092 |
| 105 | Renal tubular acidosis (HP:0001947) | 2.27132471 |
| 106 | Hypophosphatemic rickets (HP:0004912) | 2.25229829 |
| 107 | Microvesicular hepatic steatosis (HP:0001414) | 2.24830937 |
| 108 | Visual hallucinations (HP:0002367) | 2.24337662 |
| 109 | Nephrolithiasis (HP:0000787) | 2.23666433 |
| 110 | Hypoalphalipoproteinemia (HP:0003233) | 2.23154570 |
| 111 | Severe combined immunodeficiency (HP:0004430) | 2.22397317 |
| 112 | Abnormal urine phosphate concentration (HP:0012599) | 2.22130595 |
| 113 | CNS demyelination (HP:0007305) | 2.21439791 |
| 114 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.20442949 |
| 115 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.19898790 |
| 116 | Hepatocellular carcinoma (HP:0001402) | 2.19002876 |
| 117 | Hepatic necrosis (HP:0002605) | 2.17073663 |
| 118 | Symptomatic seizures (HP:0011145) | 2.16459122 |
| 119 | Spontaneous abortion (HP:0005268) | 2.14125611 |
| 120 | Abnormality of T cell physiology (HP:0011840) | 2.12423537 |
| 121 | Agammaglobulinemia (HP:0004432) | 2.10508974 |
| 122 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.10357850 |
| 123 | Methylmalonic aciduria (HP:0012120) | 2.10267372 |
| 124 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.09788569 |
| 125 | Status epilepticus (HP:0002133) | 2.09717374 |
| 126 | Acute encephalopathy (HP:0006846) | 2.09001252 |
| 127 | Tetraplegia (HP:0002445) | 2.08850925 |
| 128 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.08671487 |
| 129 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.08671487 |
| 130 | Focal motor seizures (HP:0011153) | 2.08097198 |
| 131 | Mutism (HP:0002300) | 2.06729234 |
| 132 | Slow saccadic eye movements (HP:0000514) | 2.06609784 |
| 133 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.05961748 |
| 134 | Lactic acidosis (HP:0003128) | 2.04896708 |
| 135 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.03055441 |
| 136 | Metaphyseal dysplasia (HP:0100255) | 2.02975306 |
| 137 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.02973513 |
| 138 | Increased muscle lipid content (HP:0009058) | 2.02858278 |
| 139 | Hypoproteinemia (HP:0003075) | 2.01678709 |
| 140 | Steatorrhea (HP:0002570) | 2.01441146 |
| 141 | Cholecystitis (HP:0001082) | 1.99723965 |
| 142 | Abnormal gallbladder physiology (HP:0012438) | 1.99723965 |
| 143 | Abnormality of T cell number (HP:0011839) | 1.98907450 |
| 144 | Progressive microcephaly (HP:0000253) | 1.98612237 |
| 145 | Cerebral hypomyelination (HP:0006808) | 1.97780427 |
| 146 | Sensory axonal neuropathy (HP:0003390) | 1.95837136 |
| 147 | Thyroiditis (HP:0100646) | 1.94139451 |
| 148 | Hypophosphatemia (HP:0002148) | 1.89072261 |
| 149 | Combined immunodeficiency (HP:0005387) | 1.88969181 |
| 150 | Choreoathetosis (HP:0001266) | 1.88692265 |
| 151 | Exercise intolerance (HP:0003546) | 1.87145746 |
| 152 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.86861218 |
| 153 | Absence seizures (HP:0002121) | 1.86505837 |
| 154 | Abnormality of T cells (HP:0002843) | 1.85743488 |
| 155 | Diplopia (HP:0000651) | 1.85087790 |
| 156 | Abnormality of binocular vision (HP:0011514) | 1.85087790 |
| 157 | Myokymia (HP:0002411) | 1.83960233 |
| 158 | Abnormality of glycolysis (HP:0004366) | 1.83415091 |
| 159 | Increased serum pyruvate (HP:0003542) | 1.83415091 |
| 160 | Leukodystrophy (HP:0002415) | 1.83361151 |
| 161 | Abnormality of complement system (HP:0005339) | 1.83231987 |
| 162 | Hypercholesterolemia (HP:0003124) | 1.81592320 |
| 163 | Anxiety (HP:0000739) | 1.79670898 |
| 164 | Neuronal loss in central nervous system (HP:0002529) | 1.79080164 |
| 165 | Respiratory failure (HP:0002878) | 1.77844293 |
| 166 | Conjunctival hamartoma (HP:0100780) | 1.76670316 |
| 167 | Impaired vibratory sensation (HP:0002495) | 1.76390286 |
| 168 | Acute hepatic failure (HP:0006554) | 1.76220905 |
| 169 | Gaze-evoked nystagmus (HP:0000640) | 1.74675081 |
| 170 | Reduced antithrombin III activity (HP:0001976) | 1.73113379 |
| 171 | Exertional dyspnea (HP:0002875) | 1.72537893 |
| 172 | Abnormality of the prostate (HP:0008775) | 1.72283548 |
| 173 | T lymphocytopenia (HP:0005403) | 1.71176654 |
| 174 | Abnormality of renal resorption (HP:0011038) | 1.71067743 |
| 175 | Dialeptic seizures (HP:0011146) | 1.70436754 |
| 176 | IgG deficiency (HP:0004315) | 1.69789708 |
| 177 | Pancytopenia (HP:0001876) | 1.69740523 |
| 178 | Posterior subcapsular cataract (HP:0007787) | 1.67144535 |
| 179 | Abnormality of the basal ganglia (HP:0002134) | 1.65537183 |
| 180 | Action tremor (HP:0002345) | 1.65212628 |
| 181 | Generalized tonic-clonic seizures (HP:0002069) | 1.64377879 |
| 182 | Tongue fasciculations (HP:0001308) | 1.63266161 |
| 183 | Hypokinesia (HP:0002375) | 1.63138258 |
| 184 | Cerebral hemorrhage (HP:0001342) | 1.63008441 |
| 185 | Recurrent viral infections (HP:0004429) | 1.62337701 |
| 186 | Bundle branch block (HP:0011710) | 1.61411493 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OXSR1 | 5.23891175 |
| 2 | WNK4 | 4.94706718 |
| 3 | WNK3 | 4.61975882 |
| 4 | MST4 | 4.32111621 |
| 5 | EPHA4 | 3.82982442 |
| 6 | BCKDK | 3.59629651 |
| 7 | STK39 | 3.22612813 |
| 8 | NTRK3 | 2.98452614 |
| 9 | TESK1 | 2.79774502 |
| 10 | EIF2AK3 | 2.75621067 |
| 11 | MAP2K4 | 2.39888113 |
| 12 | NUAK1 | 2.19879156 |
| 13 | DAPK2 | 2.13439688 |
| 14 | CAMKK2 | 2.12938522 |
| 15 | EIF2AK1 | 2.08505612 |
| 16 | MAP2K6 | 1.98688231 |
| 17 | MAP3K4 | 1.98477822 |
| 18 | CCNB1 | 1.85440737 |
| 19 | VRK2 | 1.82757380 |
| 20 | SGK494 | 1.76557762 |
| 21 | SGK223 | 1.76557762 |
| 22 | SCYL2 | 1.67899937 |
| 23 | BUB1 | 1.66892124 |
| 24 | KSR2 | 1.61425709 |
| 25 | MAP3K9 | 1.52390356 |
| 26 | MAP2K7 | 1.49673797 |
| 27 | PHKG2 | 1.47697414 |
| 28 | PHKG1 | 1.47697414 |
| 29 | MST1R | 1.41914323 |
| 30 | MAP3K13 | 1.41819272 |
| 31 | MINK1 | 1.36069580 |
| 32 | PAK6 | 1.31287266 |
| 33 | ALK | 1.26585307 |
| 34 | PBK | 1.24548986 |
| 35 | NME2 | 1.24358273 |
| 36 | PINK1 | 1.23073647 |
| 37 | PTK2B | 1.22009192 |
| 38 | RIPK4 | 1.21910647 |
| 39 | CASK | 1.19875191 |
| 40 | MAP3K12 | 1.18807094 |
| 41 | CDK8 | 1.18551088 |
| 42 | KSR1 | 1.17550457 |
| 43 | STK38L | 1.15262024 |
| 44 | ERBB4 | 1.15026315 |
| 45 | TXK | 1.12437845 |
| 46 | MAP3K7 | 1.09894921 |
| 47 | PLK2 | 1.06067380 |
| 48 | ARAF | 1.05967708 |
| 49 | STK38 | 1.05748806 |
| 50 | SGK2 | 1.04663495 |
| 51 | DAPK1 | 1.04363310 |
| 52 | GRK6 | 1.03825814 |
| 53 | ABL2 | 1.03383252 |
| 54 | PDK3 | 1.01933833 |
| 55 | PDK4 | 1.01933833 |
| 56 | PAK3 | 1.01153149 |
| 57 | PRKCG | 0.98911277 |
| 58 | NTRK1 | 0.98816558 |
| 59 | FGFR4 | 0.97844233 |
| 60 | CAMK2B | 0.97350009 |
| 61 | STK24 | 0.94344442 |
| 62 | CAMK2A | 0.93749964 |
| 63 | SIK2 | 0.92064238 |
| 64 | EIF2AK2 | 0.91296259 |
| 65 | STK16 | 0.90735750 |
| 66 | PLK3 | 0.90720712 |
| 67 | PDPK1 | 0.90278548 |
| 68 | WNK1 | 0.87288906 |
| 69 | SGK3 | 0.85789297 |
| 70 | NEK6 | 0.82928432 |
| 71 | MAP3K14 | 0.81338348 |
| 72 | MAP3K2 | 0.79484125 |
| 73 | SGK1 | 0.79008284 |
| 74 | TBK1 | 0.78545907 |
| 75 | BMPR2 | 0.78063877 |
| 76 | CAMK2G | 0.78004041 |
| 77 | GRK5 | 0.77979216 |
| 78 | NEK1 | 0.77691447 |
| 79 | PDK1 | 0.77199103 |
| 80 | TAF1 | 0.76419492 |
| 81 | MAPK12 | 0.75858701 |
| 82 | PRKCZ | 0.73759601 |
| 83 | SYK | 0.73737839 |
| 84 | CDK5 | 0.73323801 |
| 85 | ERBB3 | 0.70098354 |
| 86 | INSRR | 0.69999285 |
| 87 | MAPK11 | 0.67881310 |
| 88 | FGFR2 | 0.65723409 |
| 89 | FES | 0.65631150 |
| 90 | TRPM7 | 0.65478557 |
| 91 | MAP3K6 | 0.65110179 |
| 92 | RAF1 | 0.64306376 |
| 93 | IKBKE | 0.62891833 |
| 94 | MARK1 | 0.61798674 |
| 95 | FRK | 0.61183228 |
| 96 | SIK3 | 0.61082825 |
| 97 | TESK2 | 0.60596147 |
| 98 | CDK19 | 0.60152025 |
| 99 | MUSK | 0.59991830 |
| 100 | ZAK | 0.58501432 |
| 101 | SIK1 | 0.57069608 |
| 102 | TLK1 | 0.57025888 |
| 103 | RPS6KB2 | 0.55999807 |
| 104 | CAMKK1 | 0.55801415 |
| 105 | PDK2 | 0.55011554 |
| 106 | PRKCQ | 0.54791450 |
| 107 | TNK2 | 0.54595403 |
| 108 | FER | 0.54121913 |
| 109 | FGR | 0.54002120 |
| 110 | ITK | 0.53432335 |
| 111 | RET | 0.53068664 |
| 112 | TEC | 0.52801866 |
| 113 | BMPR1B | 0.51681497 |
| 114 | BRSK1 | 0.51581278 |
| 115 | JAK1 | 0.51345954 |
| 116 | CAMK2D | 0.50296555 |
| 117 | MET | 0.49001233 |
| 118 | NME1 | 0.48972412 |
| 119 | MAP3K1 | 0.47042851 |
| 120 | LATS2 | 0.46103405 |
| 121 | PKN1 | 0.45231877 |
| 122 | VRK1 | 0.44691046 |
| 123 | PRKACG | 0.44555033 |
| 124 | PRKAA2 | 0.44539257 |
| 125 | EPHB1 | 0.44020489 |
| 126 | CAMK1 | 0.41897374 |
| 127 | GSK3A | 0.41580327 |
| 128 | MAP2K1 | 0.41580275 |
| 129 | PRKCI | 0.41408419 |
| 130 | IKBKB | 0.40965358 |
| 131 | TSSK6 | 0.40789931 |
| 132 | STK11 | 0.40781248 |
| 133 | PRKD3 | 0.40776389 |
| 134 | MAP3K11 | 0.40499186 |
| 135 | CSNK1G2 | 0.40497005 |
| 136 | PRKCA | 0.39592662 |
| 137 | PNCK | 0.39259252 |
| 138 | ERN1 | 0.39222953 |
| 139 | TRIM28 | 0.37372522 |
| 140 | TAOK3 | 0.35742245 |
| 141 | PIK3CG | 0.33722524 |
| 142 | PRKACA | 0.33689804 |
| 143 | PTK2 | 0.33076113 |
| 144 | JAK2 | 0.32868803 |
| 145 | MAPKAPK5 | 0.32739573 |
| 146 | NTRK2 | 0.32728694 |
| 147 | SRPK1 | 0.32221098 |
| 148 | TNIK | 0.31931299 |
| 149 | STK3 | 0.31900632 |
| 150 | PRPF4B | 0.31854340 |
| 151 | JAK3 | 0.30639497 |
| 152 | CDK14 | 0.29327244 |
| 153 | DAPK3 | 0.28117438 |
| 154 | MAPKAPK3 | 0.27288484 |
| 155 | PRKCH | 0.26431278 |
| 156 | ACVR1B | 0.25489582 |
| 157 | UHMK1 | 0.25355722 |
| 158 | CDK18 | 0.23772734 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.67643138 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.42817262 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.29554720 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.15936983 |
| 5 | One carbon pool by folate_Homo sapiens_hsa00670 | 3.08563301 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.90367124 |
| 7 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.87407962 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.86347882 |
| 9 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.82433972 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.67485843 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.65131919 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.55750030 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.48902493 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.40103592 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.34352261 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.28349743 |
| 17 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.24375494 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.22064832 |
| 19 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.02078713 |
| 20 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.89486458 |
| 21 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.89270279 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.87678151 |
| 23 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.84975803 |
| 24 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.80251374 |
| 25 | Protein export_Homo sapiens_hsa03060 | 1.80235871 |
| 26 | DNA replication_Homo sapiens_hsa03030 | 1.76406634 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.75382914 |
| 28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.73626879 |
| 29 | Bile secretion_Homo sapiens_hsa04976 | 1.72427113 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.64252903 |
| 31 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.63703844 |
| 32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.61847230 |
| 33 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.61657871 |
| 34 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.58825389 |
| 35 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.58174307 |
| 36 | Histidine metabolism_Homo sapiens_hsa00340 | 1.57654890 |
| 37 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.54117785 |
| 38 | Allograft rejection_Homo sapiens_hsa05330 | 1.54085707 |
| 39 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.51521351 |
| 40 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.48156923 |
| 41 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.46824133 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.45329815 |
| 43 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.44623551 |
| 44 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.43191285 |
| 45 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.40573393 |
| 46 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.40344338 |
| 47 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.33511376 |
| 48 | Mismatch repair_Homo sapiens_hsa03430 | 1.31979351 |
| 49 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.27101210 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 1.26393543 |
| 51 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.26307105 |
| 52 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.22798261 |
| 53 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.22172833 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.21930305 |
| 55 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.18120529 |
| 56 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.17008371 |
| 57 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.16683781 |
| 58 | Retinol metabolism_Homo sapiens_hsa00830 | 1.15454155 |
| 59 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.13690859 |
| 60 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.12801009 |
| 61 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.12262019 |
| 62 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.12164073 |
| 63 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.06529106 |
| 64 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.05134681 |
| 65 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.04599644 |
| 66 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.04537474 |
| 67 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.03340124 |
| 68 | Homologous recombination_Homo sapiens_hsa03440 | 1.02070066 |
| 69 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.01279501 |
| 70 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.99268677 |
| 71 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.98731865 |
| 72 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.93593632 |
| 73 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.92514109 |
| 74 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.91326761 |
| 75 | Asthma_Homo sapiens_hsa05310 | 0.88323054 |
| 76 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.86146912 |
| 77 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.85427687 |
| 78 | Purine metabolism_Homo sapiens_hsa00230 | 0.83517386 |
| 79 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.81465452 |
| 80 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.79161832 |
| 81 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.76507335 |
| 82 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76222673 |
| 83 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.73532465 |
| 84 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.73484962 |
| 85 | RNA polymerase_Homo sapiens_hsa03020 | 0.72804728 |
| 86 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.72756710 |
| 87 | Lysine degradation_Homo sapiens_hsa00310 | 0.71799777 |
| 88 | Olfactory transduction_Homo sapiens_hsa04740 | 0.70235350 |
| 89 | RNA degradation_Homo sapiens_hsa03018 | 0.68769200 |
| 90 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.68387998 |
| 91 | ABC transporters_Homo sapiens_hsa02010 | 0.66331230 |
| 92 | Nicotine addiction_Homo sapiens_hsa05033 | 0.65036552 |
| 93 | Circadian rhythm_Homo sapiens_hsa04710 | 0.63812559 |
| 94 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.61170449 |
| 95 | Huntingtons disease_Homo sapiens_hsa05016 | 0.59013074 |
| 96 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.55998455 |
| 97 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.51979817 |
| 98 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.51900809 |
| 99 | Phototransduction_Homo sapiens_hsa04744 | 0.50363151 |
| 100 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49280832 |
| 101 | Base excision repair_Homo sapiens_hsa03410 | 0.48601935 |
| 102 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.47897779 |
| 103 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.47832054 |
| 104 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.45948468 |
| 105 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.45491017 |
| 106 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.44804161 |
| 107 | Sulfur relay system_Homo sapiens_hsa04122 | 0.44524141 |
| 108 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.44331087 |
| 109 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.44029855 |
| 110 | GABAergic synapse_Homo sapiens_hsa04727 | 0.43431591 |
| 111 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.42577181 |
| 112 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.42383854 |
| 113 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38979120 |
| 114 | RNA transport_Homo sapiens_hsa03013 | 0.38585098 |
| 115 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.36180797 |
| 116 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.35072582 |
| 117 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.33891538 |
| 118 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.33698707 |
| 119 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.33136920 |
| 120 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.31700085 |
| 121 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.27945535 |
| 122 | Alzheimers disease_Homo sapiens_hsa05010 | 0.26921670 |
| 123 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.25845818 |
| 124 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.25781933 |
| 125 | Mineral absorption_Homo sapiens_hsa04978 | 0.25170967 |
| 126 | Salivary secretion_Homo sapiens_hsa04970 | 0.24714512 |
| 127 | Parkinsons disease_Homo sapiens_hsa05012 | 0.24029602 |
| 128 | Long-term potentiation_Homo sapiens_hsa04720 | 0.23810247 |
| 129 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23111379 |
| 130 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.22218122 |
| 131 | Circadian entrainment_Homo sapiens_hsa04713 | 0.22207346 |
| 132 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.17516899 |
| 133 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.15437204 |
| 134 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.14736829 |
| 135 | Prion diseases_Homo sapiens_hsa05020 | 0.14634407 |
| 136 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.13891850 |
| 137 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.12794115 |
| 138 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.12296386 |
| 139 | Morphine addiction_Homo sapiens_hsa05032 | 0.11605052 |
| 140 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.09411389 |
| 141 | Insulin secretion_Homo sapiens_hsa04911 | 0.09134191 |
| 142 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.07869607 |
| 143 | Renin secretion_Homo sapiens_hsa04924 | 0.06718020 |
| 144 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.06291887 |
| 145 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.05247389 |
| 146 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.04140943 |

